Skip to main content
Have a personal or library account? Click to login
Acute coronary syndrome without documented standard modifiable risk factors and the stress hyperglycaemia ratio in an Indonesian percutaneous coronary intervention registry Cover

Acute coronary syndrome without documented standard modifiable risk factors and the stress hyperglycaemia ratio in an Indonesian percutaneous coronary intervention registry

Open Access
|Nov 2026
Read online

References

  1. Figtree GA, Vernon ST, Hadziosmanovic N, Sundström J, Alfredsson J, Arnott C, et al. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data. Lancet. 2021;397(10279):1085–1094. doi:10.1016/S0140-6736(21)00272-5.
  2. Vernon ST, Coffey S, D'Souza M, Chow CK, Kilian J, Hyun K, et al. ST-segment-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors — how common are they, and what are their outcomes? J Am Heart Assoc. 2019;8(21):e013296. doi:10.1161/JAHA.119.013296.
  3. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–952. doi:10.1016/S0140-6736(04)17018-9.
  4. Kong G, Chew NWS, Ng CH, Chin YH, Lim OZH, Ambhore A, et al. Prognostic outcomes in acute myocardial infarction patients without standard modifiable risk factors: a multiethnic study of 8,680 Asian patients. Front Cardiovasc Med. 2022;9:869168. doi:10.3389/fcvm.2022.869168.
  5. Kong G, Chew NWS, Ng CH, Chin YH, Zeng R, Foo R, et al. Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study of 5400 Asian patients. J Thromb Thrombolysis. 2022;54(4):569–578. doi:10.1007/s11239-022-02704-7.
  6. Sheikhy A, Fallahzadeh A, Jameie M, Aghajani H, Hosseini K. In-hospital and 1-year outcomes of patients without modifiable risk factors presenting with acute coronary syndrome undergoing PCI: a sex-stratified analysis. Front Cardiovasc Med. 2023;10:1235667. doi:10.3389/fcvm.2023.1235667.
  7. Kong G, Chin YH, Chong B, Goh RSJ, Lim OZH, Ng CH, et al. Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: results from a global meta-analysis of 1,285,722 patients. Int J Cardiol. 2023;371:432–440. doi:10.1016/j.ijcard.2022.09.062.
  8. Ball J, Dinh DT, Brennan A, Ajani A, Clark DJ, Freeman M, et al. Prevalence and outcomes of patients with SMuRF-less acute coronary syndrome undergoing percutaneous coronary intervention. Open Heart. 2024;11(1):e002733. doi:10.1136/openhrt-2024-002733.
  9. Figtree GA, Vernon ST, Harmer JA, Gray MP, Arnott C, Bachour E, et al. Clinical pathway for coronary atherosclerosis in patients without conventional modifiable risk factors: JACC state-of-the-art review. J Am Coll Cardiol. 2023;82(13):1343–1359. doi:10.1016/j.jacc.2023.06.045.
  10. Jiang Z, Liu H, Qiu M, Li J, Zhao W, Zhang D, et al. Long-term outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention without standard modifiable cardiovascular risk factors: findings from the OPT-CAD cohort. BMC Med. 2025;23:112. doi:10.1186/s12916-025-03933-2.
  11. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773–778. doi:10.1016/S0140-6736(99)08415-9.
  12. Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O'Dea H, Stranks SN, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100(12):4490–4497. doi:10.1210/jc.2015-2660.
  13. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473–1478. doi:10.2337/dc08-0545.
  14. Xu W, Song Q, Wang X, Zhao Z, Meng X, Xia C, et al. Association of stress hyperglycemia ratio and in-hospital mortality in patients with coronary artery disease: insights from a large cohort study. Cardiovasc Diabetol. 2022;21(1):217. doi:10.1186/s12933-022-01645-y.
  15. Zeng G, Song Y, Zhang Z, Xu J, Liu Z, Tang X, et al. Stress hyperglycemia ratio and long-term prognosis in patients with acute coronary syndrome: a multicenter, nationwide study. J Diabetes. 2023;15(7):557–568. doi:10.1111/1753-0407.13400.
  16. Esdaile H, Khan S, Mayet J, Oliver N, Reddy M, Shah ASV. The association between the stress hyperglycaemia ratio and mortality in cardiovascular disease: a meta-analysis and systematic review. Cardiovasc Diabetol. 2024;23(1):412. doi:10.1186/s12933-024-02454-1.
  17. Kahn MG, Callahan TJ, Barnard J, Bauck AE, Brown J, Davidson BN, et al. A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC). 2016;4(1):1244.
  18. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–3826. doi:10.1093/eurheartj/ehad191.
  19. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X.
  20. Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749. doi:10.1056/NEJMoa2102953.
  21. Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80(1):27–38. doi:10.1093/biomet/80.1.27.
  22. Baskoro SS, Rahma OA, Arthalia VDR, Maulana MZH, Waranugraha Y, Rohman MS. Predictor for premature coronary artery disease (PCAD) in Asian populations: a meta-analysis. Heart Sci J. 2026;7(3):23–31. doi:10.21776/ub.hsj.2026.007.03.5.
  23. Anderson JL, Knight S, May HT, Le VT, Almajed J, Bair TL, et al. Cardiovascular outcomes of ST-elevation myocardial infarction (STEMI) patients without standard modifiable risk factors (SMuRF-less): the Intermountain Healthcare experience. J Clin Med. 2023;12(1):75. doi:10.3390/jcm12010075.
DOI: https://doi.org/10.2478/rjc-2026-0033 | Journal eISSN: 2734-6382 | Journal ISSN: 1220-658X
Language: English
Published on: Nov 6, 2026
Published by: Romanian Society of Cardiology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Sahlan Abadi, Mohammad Saifur Rohman, Wella Karolina, published by Romanian Society of Cardiology
This work is licensed under the Creative Commons Attribution 4.0 License.